MA
RPRX icon

Montag & Associates’s Royalty Pharma RPRX Stock Holding History

Montag & Associates’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed -$871 – 1046
2024
Q2 		$871 Hold
33
– – ﹤0.01% 948
2024
Q1 		$1K Hold
33
– – ﹤0.01% 926
2023
Q4 		$927 Hold
33
– – ﹤0.01% 886
2023
Q3 		$896 Hold
33
– – ﹤0.01% 874
2023
Q2 		$1.01K Sell
33
-5
-13% -$169 ﹤0.01% 890
2023
Q1 		$1.37K Hold
38
– – ﹤0.01% 878
2022
Q4 		$1.5K Buy
+38
New +$1.59K ﹤0.01% 882

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return